FindTrial
Sign In

Cancer survival of male BRCA mutation carriers: systematic review and meta-analysis

Cancer survival of male BRCA mutation carriers: systematic review and meta-analysis - Cancer survival of male BRCA mutation carriers: systematic review and meta-analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000044600
Enrollment
Unknown
Registered
2021-06-21
Start date
2020-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

male breast cancer, prostate cancer, pancreatic cancer, colon cancer

Interventions

None listed

Sponsors

Hiroshima Asa city Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: The studies written in English literature searched with the keywords ,"cancer", "breast cancer", "prostate cancer", "pancreatic cancer", "male", "BRCA1", "BRCA2", "BRCA", "colon cancer", "prognosis", "survival" in PubMed, OVID MEDLINE, and Scopus database.

Exclusion criteria

Exclusion criteria: Review articles, case reports, commentaries, published conference abstracts, and letters were excluded.

Design outcomes

Primary

MeasureTime frame
Comparing the prognosis of male breast cancer, prostate cancer, pancreatic cancer, and colorectal cancer in male BRCA1 / 2 mutant carriers with non-mutant individuals—

Countries

Japan

Contacts

Public ContactNoriko Goda

Hiroshima Asa city Hospital Department of breast surgery

yoshimuranoriko32@gmail.com082-815-5211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026